ArticleScientific reports2026
Assessing the prevalence of non-use of cervical cancer screening in Khouribga, Morocco.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Prevalence and determinants of human papillomavirus vaccine hesitancy among parents of young girls in Morocco.Scientific reports · 2026Article
- Challenges to human papillomavirus vaccination among young girls in Morocco: A national cross-sectional study.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early detection of cervical cancer is crucial for reducing disease progression and improving recovery rates. Screening delays increase the risk of advanced cancer and metastasis. This study assessed the prevalence of non-use of cervical cancer screening in Khouribga and identified associated risk factors. A cross-sectional study was done with 499 women aged 30 to 49 years who visited the Khouribga healthcare centers between March and December 2024. A face-to-face questionnaire was used to collect information about sociodemographic variables, knowledge of cervical cancer, screening awareness, healthcare interactions, and social influences. A multivariate analysis found key risk factors for not using cervical cancer screening. Among the 458 participants (91.8%) who had not undergone screening, the mean age was 38.9 ± 6.1 years. The main risk factors for not participating in cervical cancer screening were lack of awareness about the target screening population (APR = 10.83; CI [2.22-52.7]) and unawareness of the availability of free screening services (APR = 9.82; CI [2.69-35.7]). The high prevalence of non-use of cervical cancer screenings highlights the pressing need for focused awareness initiatives. To increase participation and lessen the burden of cervical cancer, education must be strengthened, and the availability and eligibility of free screening services must be made obvious.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.